Elanco Animal Health ELAN
NYSE ELAN
$23.97 +0.41 (+1.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026)

Elanco Animal Health (ELAN) posted Amortization - Intangibles of $138.0 million for Q1 2026, down 0.72% sequentially from $139.0 million in Q4 2025, and up 7.81% YoY from $128.0 million in Q1 2025.

Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026) Analysis & Trends

Elanco Animal Health has reported Amortization - Intangibles for 10 years, with the latest figure at $138.0 million in Q1 2026.

  • Quarterly Amortization - Intangibles rose 7.81% year-over-year to $138.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $553.0 million (up 5.94% YoY) and the FY2025 annual result came in at $543.0 million, up 3.04% from the prior year.
  • Amortization - Intangibles retreated to $138.0 million in Q1 2026 per ELAN's latest filing, from $139.0 million in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $140.0 million in Q3 2023 and troughed at $128.0 million in Q3 2022.
  • A 5-year average of $134.4 million and a median of $134.0 million in 2023 frame the typical range for Amortization - Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles fell 9.22% in 2022, then gained 9.38% in 2023.
  • Over 5 years, Amortization - Intangibles stood at $130.0 million in 2022, then rose by 6.15% to $138.0 million in 2023, then fell by 5.8% to $130.0 million in 2024, then grew by 6.92% to $139.0 million in 2025, then retreated by 0.72% to $138.0 million in 2026.
  • According to Business Quant data, Amortization - Intangibles over the past three periods registered $138.0 million, $139.0 million, and $140.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 139.00 Mn
Mar 31, 2026 138.00 Mn
Dec 31, 2025 139.00 Mn
Sep 30, 2025 140.00 Mn
Jun 30, 2025 136.00 Mn
Mar 31, 2025 128.00 Mn
Dec 31, 2024 130.00 Mn
Sep 30, 2024 133.00 Mn
Jun 30, 2024 131.00 Mn
Mar 31, 2024 133.00 Mn
Dec 31, 2023 138.00 Mn
Sep 30, 2023 140.00 Mn
Jun 30, 2023 136.00 Mn
Mar 31, 2023 134.00 Mn
Dec 31, 2022 130.00 Mn
Sep 30, 2022 128.00 Mn
Jun 30, 2022 133.00 Mn
Mar 31, 2022 137.00 Mn
Dec 31, 2021 139.00 Mn
Sep 30, 2021 141.00 Mn